Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pneumonia diagnostic technology gains US patent:

This article was originally published in Clinica

Executive Summary

US firm Genomics Collaborative has been awarded a US patent covering a technology that could lead to the development of a diagnostic screening tool for determining predisposition to pneumonia and sepsis. "By identifying factors that predispose patients to pneumonia and even an increased risk of death, we can select and develop aggressive treatment regimens, says Dr Kevin Krenitsky, the firm's medical director. The patent is entitled "Method of diagnosing and treating community acquired pneumonia (CAP) associated with the A-allele of TNFalpha-238 polymorphism."





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts